Carbon-ion radiation enhances migration ability and invasiveness of the pancreatic cancer cell, PANC-1, inv itro

Cancer Science

Volumn 103, Issue 4, 2012, Pages 677-683

  Fujita, Mayumi ^a   Otsuka, Yoshimi ^a   Imadome, Kaori ^a   Endo, Satoshi ^a   Yamada, Shigeru ^a   Imai, Takashi ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; APROTININ; CARBON; PEPSTATIN; PLASMIN; UROKINASE;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER RADIOTHERAPY; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IN VITRO STUDY; ION THERAPY; PANCREAS CANCER; PRIORITY JOURNAL; RADIATION DOSE;

CARBON; CELL LINE, TUMOR; CELL MOVEMENT; HUMANS; IONS; MATRIX METALLOPROTEINASE 2; PANCREATIC NEOPLASMS; PLASMINOGEN ACTIVATORS; RHO-ASSOCIATED KINASES; SERINE PROTEASES;

EID: 84859005046     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.02190.x     Document Type: Article

References (40)

1. Wong HH, Lemoine NR. Pancreatic cancer: molecular pathogenesis and new therapeutic targets. Nat Rev Gastroenterol Hepatol 2009; 6: 412-22.
2. Lau WY, Lai EC. Development and controversies of adjuvant therapy for pancreatic cancer. Hepatobiliary Pancreat Dis Int 2008; 7: 121-5.
3. Krishnan S, Rena V, Janjan NAet al.Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation. Cancer 2006; 107: 2589-96.
4. Okada T, Kamada T, Tsuji Het al.Carbon ion radiotherapy: clinical experiences at National Institute of Radiological Science (NIRS). J Radiat Res 2010; 51: 355-64.
5. Fokas E, Kraft G, An H, Engenhart-Cabillic R. Ion beam radiobiology and cancer: time to update ourselves. Biochim Biophys Acta 2009; 1796: 216-29.
6. Schulz-Ertner D, Tsujii H. Particle radiation therapy using proton and heavier ion beams. J Clin Oncol 2007; 25: 953-64.
7. Tobias CA, Blakely EA, Alpen ELet al.Molecular and cellular radiobiology of heavy ions. Int J Radiat Oncol Biol Phys 1982; 8: 2109-20.
8. Matsui Y, Asano T, Kenmochi T, Iwakawa M, Imai T, Ochiai T. Effects of carbon-ion beams on human pancreatic cancer cell lines that differ in genetic status. Am J Clin Oncol 2004; 27: 24-8.
9. Hamada N, Imaoka T, Masunaga Set al.Recent advances in the biology of heavy-ion cancer therapy. J Radiat Res 2010; 51: 365-83.
10. Kleg S, Buchler P, Ludwig R, Buchler MW, Friess H. Invasion and metastasis in pancreatic cancer. Mol Cancer 2003; 2: 14.
11. Wild-Bode C, Weller M, Rimber A, Dichigans J, Wick W. Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma. Cancer Res 2001; 61: 2744-50.
12. Qian LW, Mizumoto K, Urashima Tet al.Radiation-induced increase in invasive potential of human pancreatic cancer cells and its blockade by a matrix metalloproteinase inhibitor, CGS27023. Clin Cancer Res 2002; 8: 1223-7.
13. Fujita M, Otsuka Y, Yamada S, Iwakawa M, Imai T. X-ray irradiation and Rho-kinase inhibitor additively induce invasiveness of the cells of the pancreatic cancer line, MIAPaCa-2, which exhibits mesenchymal and amoeboid motility. Cancer Sci 2011; 102: 792-8.
14. Ogata T, Teshima T, Kagawa Ket al.Particle irradiation suppresses metastatic potential of cancer cells. Cancer Res 2005; 65: 113-20.
15. Akino Y, Teshima T, Kihara Aet al.Carbon-ion beam irradiation effectively suppresses migration and invasion of human non-small-cell lung cancer cells. Int J Radiat Oncol Biol Phys 2009; 75: 475-81.
16. Goetze K, Scholz M, Taucher-Scholz G, Mueller-Klieser W. The impact of conventional and heavy ion irradiation on tumor cell migration in vitro. Int J Radiat Biol 2007; 83: 889-96.
17. Wolf K, Mazo I, Leung Het al.Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol 2003; 160: 267-77.
18. Sanz-Morero V, Gadea G, Ahn Jet al.Rac activation and inactivation control plasticity of tumor cell movement. Cell 2008; 135: 510-23.
19. Pinner S, Sahai E. PDK1 regulates cancer cell motility by antagonising inhibition of ROCK1 by RhoE. Nat Cell Biol 2008; 10: 127-37.
20. Yamazaki D, Kurisu S, Takenawa T. Involvement of Rac and Rho signaling in cancer cell motility in 3D substrates. Oncogene 2009; 28: 1570-83.
21. Narumiya S, Tanji M, Ishizaki T. Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion. Cancer Metastasis Rev 2009; 28: 65-76.
22. Friedl P, Wolf K. Plasticity of cell migration: a multiscale tuning model. J Cell Biol 2010; 188: 11-9.
23. Imadome K, Iwakawa M, Nojiri Ket al.Upregulation of stress-response genes with cell cycle arrest induced by carbon ion irradiation in multiple murine tumors models. Cancer Biol Ther 2008; 7: 208-17.
24. Albini AY, Iwamoto H, Kleinman KGet al.A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987; 47: 3239-45.
25. Kaneshiro ES, Wyder MA, Wu YP, Cushion MT. Reliability of calcein acetoxy methyl ester and ethidium homodimer or propidium iodide for viability assessment of microbes. J Microbiol Methods 1993; 17: 1-16.
26. Deshet N, Lupu-Meiri M, Espinoza Iet al.Plasminogen-induced aggregation of PANC-1 cells requires conversion to plasmin and is inhibited by endogenous plasminogen activator inhibitor-1. J Cell Physiol 2008; 216: 632-9.
27. Mason SD, Joyce JA. Proteolytic networks in cancer. Trends Cell Biol 2011; 21: 228-37.
28. Blasi F, Carmeliet P. uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol 2002; 3: 932-43.
29. Ossowski L, Aguirre-Ghiso JA. Urokinase receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth. Curr Opin Cell Biol 2000; 12: 613-20.
30. Skrzydlewska E, Sulkowsa M, Koda M, Sulkowski S. Proteolytic-antiproteolytic balance and its regulation in carcinogenesis. World J Gastroenterol 2005; 11: 1251-66.
31. Whiteman HJ, Weeks ME, Dowen SEet al.The role of S100P in the invasion of pancreatic cancer cells is mediated through cytoskeletal changes and regulation of cathepsin D. Cancer Res 2011; 67: 8633-42.
32. Cantero D, Friess H, Deflorin Jet al.Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma. Br J Cancer 1997; 75: 388-95.
33. Nielsen A, Scarlett CJ, Samra JSet al.Significant overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma using real-time quantitative reverse transcription polymerase chain reaction. J Gastroenterol Hepatol 2005; 20: 256-63.
34. Nguyen DH, Catling AD, Webb DJet al.Myosin light chain kinase functions downstream of Ras/ERK to promote migration of the urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner. J Cell Biol 1999; 146: 149-64.
35. Ulisse S, Baldini E, Sorrenti S, D'Armiento M. The urokinase plasminogen activator system: a target for anti-cancer therapy. Curr Cancer Drug Targets 2009; 9: 32-71.
36. Shafman TD, Saleem A, Kyriakis J, Weichselbaum R, Kharbanda S, Kufe DW. Defective induction of stress-activated protein kinase activity in ataxia-telangiectasia cells exposed to ionizing radiation. Cancer Res 1995; 55: 3242-5.
37. Lee SA, Dritschilo A, Jung M. Impaired ionizing radiation-induced activation of a nuclear signal essential for phosphorylation of c-Jun by dually phosphorylated c-Jun amino-terminal kinases in ataxia telangiectasia fibroblasts. J Biol Chem 1998; 273: 32889-94.
38. Ahmed KM, Li JJ. NF-kappa B-mediated adaptive resistance to ionizing radiation. Free Radic Biol Med 2008; 44: 1-13.
39. Pakneshan P, Szyf M, Farias-Eisner R, Rabbani SA. Reversal of the hypomethylation status of urokinase (uPA) promoter blocks breast cancer growth and metastasis. J Biol Chem 2004; 279: 31735-44.
40. Pulukuri SM, Estes N, Patel J, Rao JS. Demethylation-linked activation of urokinase plasminogen activator is involved in progression of prostate cancer. Cancer Res 2007; 67: 930-9.